Literature DB >> 3026857

Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4.

D W Goldman, L A Gifford, T Marotti, C H Koo, E J Goetzl.   

Abstract

The distinctive characteristics of human polymorphonuclear (PMN) leukocyte receptors for leukotriene B4 (LTB4) have been elucidated by studies of binding of [3H]LTB4, the structure of protein constituents of the receptors isolated from plasma membranes, and the effects of antireceptor antibodies. A high-affinity class of 4400 receptors with a KD of 0.4 nM mediates chemotaxis and increased adherence of PMN leukocytes, whereas a low-affinity class of 270,000 receptors with a KD of 61 nM mediates the release of lysosomal enzymes and increases in oxidative metabolism. The low-affinity receptors are composed of a 60,000-dalton protein-binding unit. The high-affinity receptors are composed of the same binding unit in association with a 40,000-dalton guanine nucleotide-binding protein. That antireceptor antibodies as well as LTB4 distinguish the two classes of receptors with different functional consequences suggests the possibility of unique approaches to the regulation of leukocyte function at the receptor level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026857

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  12 in total

1.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

2.  Failure of pertussis toxin to inhibit activation of guanylate cyclase by the heat-stable enterotoxin of Escherichia coli (STa) in the T84 cell line.

Authors:  J K Crane; E L Hewlett; C S Weikel
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

3.  Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.

Authors:  N Ohmi; C Tani; K Yamada; M Fukui
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

4.  Transition of affinity states for leukotriene B4 receptors in sheep lung membranes.

Authors:  B Votta; S Mong
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

Review 5.  Leukotriene B4 and inflammatory disease.

Authors:  R M McMillan; S J Foster
Journal:  Agents Actions       Date:  1988-06

6.  In vitro effects of leukotriene B4 (LTB4) on canine PMN effector function(s).

Authors:  D F Gruber; M M D'Alesandro; T L Walden
Journal:  Agents Actions       Date:  1989-11

7.  Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrell
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

8.  A major concanavalin-A-binding cell surface protein from normal and leukemic granulocytes: isolation and characterization.

Authors:  R Hingorani; S M Zingde; A Tankkar; S H Advani; B P Gothoskar
Journal:  Ann Hematol       Date:  1992-10       Impact factor: 3.673

9.  Tumour necrosis factors modulate the affinity state of the leukotriene B4 receptor on human neutrophils.

Authors:  J Brom; J Knöller; M Köller; W König
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

Review 10.  Generation and recognition of leukotriene mediators of hypersensitivity and inflammation.

Authors:  E J Goetzl; B A Burrall; L Baud; K H Scriven; J D Levine; C H Koo
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.